Looks like TEC Edmonton has a keeper.

TEC Edmonton's latest Executive-In-Residence (E.I.R) - our in-house business experts who work closely with TEC Edmonton's client companies to ensure their business success - has it all covered.

Jason Ding has worked in research laboratories (BSc. at the University of Alberta), in the media (a weekly series on Edmonton's CBC morning radio on medical research), in business (BCom. at the University of Alberta, as an accountant, then life-sciences corporate finance with Deloitte) and in the community (Edmonton Public Library trustee, University of Alberta Senator, co-chair of the BioAlberta partnering committee).

"I started in the sciences, but I found I liked working with people more than laboratory work," says Jason of the fact he has degrees in both science and business (accounting).

And with his science degree, KPMG put him to work auditing technology companies in Vancouver and Edmonton.

Auditing was one thing. Negotiating transactions and deals was another. 

Jason was by inclination and by nature a deal maker, and Deloitte gave him that opportunity back in his hometown of Edmonton, and in fact made him a Vice-President & Director and National biotechnology deputy leader of the firm's Canadian Life Sciences and Healthcare practice.

During his time with Deloitte, Jason worked on agreements between BioMS Medical and Eli Lilly, Isotechnika and Paladin and Biovail and Valeant Pharmaceuticals.

Is there anything Jason hasn't done?

Jason will be a full-time TEC Edmonton E.I.R. as of Monday, November 21, with a primary focus in working with TEC portfolio companies in the Life Sciences industry, but he'll be available to assist all TEC client companies in corporate finances and business advisory services.

Jason joins an EIR team composed of Andrew Pryor (manager, business development),  Darrel Petras (agriculture and bio-technology), Denis Taschuk (energy), Derek Hudson (general), John Simon (regulatory affairs),  Kyle Kasawski (clean technology), Mike Cabigon (oil and gas, finance) Peter Silverstone (life sciences), Reg Joseph (life sciences), Shaheel Hooda (information technology) and Steve Jakeway (natural sciences). The business services team is headed up by TEC Edmonton Executive VP of Business Development Dr. Randy Yatscoff.

Meanwhile, TEC Edmonton will be bidding a fond farewell to E.I.R. Bern Philip (life sciences) at the end of the year. Like many executives-in-residence before him, Bern is heading back to full-time entrepreneurship with his own company Bertech Pharma. Bertech develops bio-markers for cancer diagnosis.